Saturday 17 October 2026
Export LITS’s income statement to Excel — free account
Lite Strategy, Inc.
LITS Healthcare Biotechnology
Lite Strategy, Inc.’s revenue for fiscal 2024 (year ended June 2024) was $65.3 million, up 33.8% from fiscal 2023. In the quarter to June 2026, EPS fell 11.0% and free cash flow grew 179.3%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
1.14
0.06
−5.00%
Follow LITS
| Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 4 | 6 | 4 | 4 | 3 | 5 | — | — |
P/E ratio |
39.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.07 | — | — |
Altman Z-Score |
8.11 | (0.84) | (1.64) | 0.69 | (0.98) | (2.79) | (4.17) | (8.07) | — | — |
P/S ratio |
3.78 | 102.43 | 36.47 | 13.55 | 9.22 | 1.87 | 0.90 | 0.18 | — | — |
Altman Z″-Score (non-manufacturers) |
7.00 | (1.49) | (6.04) | 1.56 | (2.45) | (4.01) | (8.00) | (18.94) | — | — |
P/FCF ratio |
25.61 | 0.00 | 0.00 | 11.28 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Beneish M-Score |
— | — | — | (0.84) | (3.44) | (2.40) | (2.12) | — | — | — |
P/Operating CF |
(27.97) | (47.70) | (22.23) | 5.44 | (28.49) | (4.90) | (3.88) | (1.05) | — | — |
P/B ratio |
1.73 | 3.29 | 3.74 | 4.88 | 6.48 | 1.45 | 1.78 | 0.58 | — | — |
Price to Tangible BV |
1.74 | 3.31 | 3.76 | 4.90 | 6.51 | 1.46 | 1.80 | 0.58 | — | — |
EV/Sales |
1.48 | 39.09 | 21.32 | 6.97 | 4.81 | (1.90) | (1.16) | (0.18) | — | — |
EV/EBITDA |
13.94 | 0.00 | 0.00 | 0.00 | 0.00 | 1.03 | 1.56 | 0.00 | — | — |
EV/Operating CF |
9.87 | (3.01) | (3.56) | 5.65 | (5.23) | 1.59 | 1.08 | 0.38 | — | — |
EV/FCF |
10.02 | (3.01) | (3.53) | 5.80 | (5.12) | 1.57 | 1.08 | 0.38 | — | — |
Quick Ratio |
11.01 | 13.03 | 5.58 | 14.97 | 7.97 | 6.68 | 4.95 | 4.59 | 13.30 | 5.34 |
Current Ratio |
11.37 | 13.23 | 5.75 | 15.17 | 8.15 | 6.84 | 5.29 | 4.88 | 13.50 | 5.74 |
Net Debt/EBITDA |
(21.69) | 3.60 | 1.61 | 7.20 | 2.55 | 2.04 | 2.77 | (1.48) | 1.05 | 0.09 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.45 | 0.02 | 0.05 | 0.19 | 0.18 | 0.23 | 0.33 | 0.81 | 0.00 | 0.00 |
Operating CF/Net income |
1.31 | 0.53 | 1.75 | (0.73) | 0.77 | 0.90 | 1.65 | (2.84) | 1.31 | 0.13 |
Capex/Depreciation |
(0.60) | 0.00 | (2.71) | (2.66) | (2.48) | (1.47) | (0.09) | 0.00 | 0.03 | 0.00 |
| 5.77% | (79.11%) | (34.19%) | (75.48%) | (65.30%) | (106.90%) | (82.66%) | 61.68% | (63.84%) | (243.02%) | |
| 5.19% | (49.97%) | (17.96%) | (32.27%) | (21.53%) | (30.95%) | (21.32%) | 21.92% | (53.45%) | (233.37%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (115.85%) |
Return on Tangible Assets |
5.29% | (41.53%) | (24.70%) | (24.07%) | (28.28%) | (37.73%) | (35.98%) | 54.19% | (94.18%) | (1,402.80%) |
Average Days of Receivables |
0.00 | 0.00 | 391.66 | 306.11 | 79.53 | 90.08 | 0.64 | 0.00 | — | — |
Research and Development Expense of Revenue |
31.13% | 1,050.43% | 657.17% | 122.73% | 199.44% | 210.44% | 107.44% | 25.36% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
37.11% | 603.39% | 296.99% | 60.23% | 70.16% | 75.04% | 67.87% | 35.68% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.82 |
Share Based Compensation of Revenue |
9.91% | 198.34% | 133.51% | 24.50% | 29.44% | 20.52% | 7.35% | 3.49% | 0.00% | 0.00% |
Graham Net Nets |
0.57 | 0.30 | 0.26 | 0.20 | 0.13 | 0.55 | 0.26 | 1.71 | — | — |
Graham Number |
27.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.25 | — | — |
Earnings Yield |
2.51% | (22.94%) | (9.52%) | (12.35%) | (14.72%) | (72.35%) | (70.36%) | 93.68% | — | — |
Free Cash Flow Yield |
3.90% | (12.69%) | (16.56%) | 8.87% | (10.19%) | (64.83%) | (119.79%) | (266.05%) | — | — |
Revenue per Share |
12.63 | 0.78 | 1.38 | 6.09 | 6.18 | 6.54 | 7.33 | 9.80 | 0.00 | 0.00 |
Operating CF per Share |
1.89 | (10.15) | (8.27) | 7.52 | (5.68) | (7.83) | (7.88) | (7.58) | (3.13) | (0.26) |
Capex per Share |
(0.03) | 0.00 | (0.06) | (0.20) | (0.13) | (0.08) | (0.01) | 0.00 | 0.00 | (2.75) |
Free Cash Flow per Share |
1.87 | (10.15) | (8.33) | 7.33 | (5.81) | (7.91) | (7.88) | (7.58) | (3.13) | (3.01) |
Cash per Share |
29.10 | 49.60 | 20.94 | 40.10 | 27.27 | 24.62 | 15.11 | 5.75 | 2.70 | 0.17 |
Shareholders Equity per Share |
27.62 | 24.36 | 13.47 | 16.92 | 8.79 | 8.42 | 3.70 | 4.96 | 2.54 | 1.20 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
27.62 | 24.36 | 13.47 | 16.92 | 8.79 | 8.42 | 3.70 | 4.96 | 2.54 | 1.20 |
Free Cash Flow |
3.44 | (21.03) | (29.64) | 33.36 | (32.67) | (49.22) | (52.52) | (50.48) | (20.83) | (104.08) |
Working Capital |
50.46 | 96.44 | 67.90 | 194.89 | 144.61 | 142.68 | 87.19 | 32.41 | 16.93 | 5.07 |
Capital Expenditures |
(0.05) | — | (0.22) | (0.89) | (0.71) | (0.48) | (0.03) | (0.01) | 0.01 | (94.96) |
Net Current Asset Value |
50.46 | 50.13 | 47.47 | 75.98 | 40.19 | 41.70 | 11.34 | 32.41 | 16.93 | 5.07 |
EV/EBIT |
14.44 | 0.00 | 0.00 | 0.00 | 0.00 | 1.02 | 1.55 | 0.00 | — | — |
Capex to Sales |
0.00 | 0.00 | 0.04 | 0.03 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
36.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.31 | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.70 | 1.66 | 0.39 | 0.31 | 0.19 | 0.20 | 0.29 | 28.78 | 0.00 | — |
Cash ROIC |
3.29% | (13.73%) | (24.21%) | 12.85% | (16.10%) | (23.93%) | (41.91%) | (70.73%) | (59.62%) | (219.91%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.33 | 1.94 | 2.26 | 4.62 | 9.64 | 0.00 | — | — |
Accounts Payable Turnover |
6.01 | 1.60 | 1.01 | 0.74 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
42.71 | 393.05 | 409.87 | 333.02 | 1,647.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Receivables |
— | — | 14.79 | 14.28 | 15.43 | 8.81 | 5.06 | — | — | — |
Average Payables |
0.83 | 2.11 | 4.22 | 3.61 | 4.40 | 7.14 | 7.03 | 4.65 | 1.67 | 0.22 |
Average Assets |
51.43 | 80.18 | 93.66 | 146.20 | 191.91 | 175.97 | 149.32 | 81.09 | 29.83 | 30.49 |
Average Common Equity |
46.25 | 50.65 | 49.19 | 62.50 | 63.26 | 50.94 | 38.52 | 28.82 | 24.98 | 29.28 |
Columns are period end dates · fundamentals updated 30 Sep 2026